| Q48788750 | Attenuated Reactive Gliosis and Enhanced Functional Recovery Following Spinal Cord Injury in Null Mutant Mice of Platelet-Activating Factor Receptor |
| Q38222477 | Building biocompatible hydrogels for tissue engineering of the brain and spinal cord |
| Q39363205 | CD36 is involved in astrocyte activation and astroglial scar formation |
| Q38875531 | CRMPs Function in Neurons and Glial Cells: Potential Therapeutic Targets for Neurodegenerative Diseases and CNS Injury |
| Q34071712 | Differential expression of Wnts after spinal cord contusion injury in adult rats |
| Q38447372 | Endogenous neural stem cell responses to stroke and spinal cord injury |
| Q37950860 | Fibrinogen as a key regulator of inflammation in disease |
| Q33853378 | Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage |
| Q37351589 | Immunological demyelination triggers macrophage/microglial cells activation without inducing astrogliosis |
| Q42872784 | Mannosylated liposomal cytidine 5′ diphosphocholine prevent age related global moderate cerebral ischemia reperfusion induced mitochondrial cytochrome c release in aged rat brain |
| Q36581080 | Recapitulate development to promote axonal regeneration: good or bad approach? |
| Q28239915 | Regeneration beyond the glial scar |
| Q42365639 | Treatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline |